Texas Oncology - San Antonio Medical Center
San Antonio, TX
Accepting patients
SUCCESSOR-1
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared to Pomalidomide, Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
- CELMoD
- Randomization
- Phase 3
Accepting patients
Teclistamab
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
- Bispecific Antibody
- BCMA
- Phase 2
- Has results